Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Serum Testosterone Concentrations Predict Incident Frailty in Men with HIV.

The Journal of clinical endocrinology and metabolism·2026
Same author

Insulinomatosis: A case report of a multifocal insulin-secreting entity.

Radiology case reports·2026
Same author

Dental disease among adults with and without HIV in the MACS/WIHS Combined Cohort Study (MWCCS).

BMC oral health·2026
Same author

Insulin deficiency is associated with early postpartum T2DM in Indian women with gestational diabetes.

Frontiers in clinical diabetes and healthcare·2026
Same author

Effect of hospitalization on cognitive and physical function in people with HIV.

AIDS (London, England)·2026
Same author

Semaglutide improves markers of cardiovascular risk in people with HIV.

AIDS (London, England)·2026
Same journal

CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.

Topics in antiviral medicine·2026
Same journal

CROI 2026: Acute and Postacute COVID-19.

Topics in antiviral medicine·2026
Same journal

CROI 2026: Advances in Epidemiology and Treatment of Viral Hepatitis.

Topics in antiviral medicine·2026
Same journal

CROI 2026: Tuberculosis and Other Infectious Complications in People With HIV.

Topics in antiviral medicine·2026
Same journal

CROI 2026: Innovations in HIV Care and Service Delivery to Improve Treatment Outcomes.

Topics in antiviral medicine·2026
Same journal

CROI 2026: Antiretroviral THerapy in Adult, Maternal, and Pediatric Populations With HIV.

Topics in antiviral medicine·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

CROI 2026: HIV Comorbidities.

Sudipa Sarkar1, Todd T Brown1

  • 1Johns Hopkins University, Baltimore, MD, USA.

Topics in Antiviral Medicine
|May 13, 2026
PubMed
Summary
This summary is machine-generated.

Aging HIV patients face numerous health challenges, including cardiovascular disease, fatty liver disease, and bone issues. Research at CROI 2026 highlights exercise benefits and treatment strategies for these conditions.

More Related Videos

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Related Experiment Videos

Last Updated: May 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Area of Science:

  • Internal Medicine
  • Infectious Diseases
  • Gerontology

Background:

  • Aging-related comorbid conditions significantly impact the health, quality of life, and survival of people with HIV (PWH).
  • The 2026 Conference on Retroviruses and Opportunistic Infections (CROI) addressed various comorbid diseases in PWH.

Purpose of the Study:

  • To review key abstracts from CROI 2026 concerning aging-related comorbidities in PWH.
  • To highlight studies with the most significant clinical impact on PWH health.

Main Methods:

  • Review of abstracts presented at CROI 2026.
  • Focus on cardiovascular diseases, hypertension, metabolic dysfunction-associated fatty liver disease, antiretroviral-related weight gain, osteoporosis, and frailty in PWH.
  • Inclusion of studies from diverse geographical settings, including lower- and middle-income countries.

Main Results:

  • Cardiovascular diseases and hypertension were key topics, with analyses from the REPRIEVE trial and global studies.
  • Metabolic dysfunction-associated fatty liver disease and weight gain associated with antiretroviral therapy were prominent.
  • High prevalence of osteoporosis and frailty in PWH in sub-Saharan Africa was documented, alongside studies on exercise and physical activity benefits.

Conclusions:

  • CROI 2026 showcased critical research on managing aging-related comorbidities in PWH.
  • Clinical management strategies for cardiovascular, metabolic, and bone health in aging PWH are evolving.
  • Further research and interventions are needed to address the complex health needs of aging PWH globally.